Chengge Shi
Wenzhou, 325000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
M2 macrophage-derived exosome nanoplatform for targeted H2S delivery to alleviate hepatic ischemia-reperfusion injury via synergistic anti-oxidative, anti-inflammatory, and anti-ferroptotic effects.
Journal: Acta biomaterialia
Published: August 19, 2025
Manganese oxide nanozyme-loaded CO-releasing halloysite nanotubes for remodeling colonic immune, microbiota, and intestinal barrier homeostasis with concurrent pain relief in ulcerative colitis.
Journal: Bioactive materials
Published: July 25, 2025
Targeted intestinal barrier repair via probiotic-derived engineered outer membrane vesicles: A 3A1M strategy with antioxidant, anti-inflammatory, anti-ferroptotic, and microbiome modulation effects.
Journal: Acta pharmaceutica Sinica. B
Published: June 24, 2025
CO-Releasing Polyoxometalates Nanozyme with Gut Mucosal Immunity and Microbiota Homeostasis Remodeling Effects for Restoring Intestinal Barrier Integrity.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: January 03, 2025
Inhibition of KIF11 ameliorates osteoclastogenesis via regulating mTORC1-mediated NF-κB signaling.
Journal: Biochemical pharmacology
Published: July 11, 2023
Structure and function of the membrane microdomains in osteoclasts.
Journal: Bone research
Published: January 10, 2023
Asiaticoside Attenuates Blood-Spinal Cord Barrier Disruption by Inhibiting Endoplasmic Reticulum Stress in Pericytes After Spinal Cord Injury.
Journal: Molecular neurobiology
Published: November 25, 2022
Praeruptorin B inhibits osteoclastogenesis by targeting GSTP1 and impacting on the S-glutathionylation of IKKβ.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: April 22, 2022
Showing 1-9 of 9
Last Updated: 09/26/2026